Aled Williams

Aled Williams is an experienced executive in the biopharmaceutical sector, currently serving as a Non Executive Director at Destiny Pharma plc since May 2022. Previously, Aled held the position of Chief Executive Officer at Enthera Pharmaceuticals from May 2022 to January 2024, and Chief Business Officer at Polyneuron Pharmaceuticals AG from September 2020 to April 2022. Aled's extensive background includes roles as Chief Commercial Officer at VectivBio and Therachon, and Vice President at Shire Pharmaceuticals, where responsibilities encompassed leadership in rare diseases and strategic product management. Early career positions included leadership roles at Bristol-Myers Squibb, Novartis, Hoffmann-La Roche, and Pfizer Pharmaceuticals. Aled's academic credentials comprise a CEDEP General Management Program from INSEAD, a Post-Graduate Diploma in Management Studies from the University of South Wales, and a BSc (Hons) in Microbiology and Biochemistry from the University of Reading.